The study on medication error at prescription stage

Abstract

Background: One of the main factors determining the quality of medical care is the medication error. Medication review is significant in preventing medical errors, improving treatment outcomes, reducing hospital stays, lower direct and indirect treatment costs. Objective: study prescription error and severity category during the results of patient’s medication review of inpatients at the Mongolia-Japan hospital, MNUMS. Materials and Methods: From January to November 2021, a total of 620 randomly selected “Patient prescription review checklist” reviewed at hospital, retrospective study model and descriptive analysis. In our study, we used a retrospective and descriptive research model using patient’s medication review evaluations based on the pharmacotherapy. Results: Medication error reported in 45.4% (n=282) at prescription stage. 75 (12%) cases of inappropriate drug dose and 11 (1.6%) cases that medicinal overlap, 7 (0.9%) contraindicated drug, 204 (30.5%) cases which the drugs are not prescribed in generic name and 282 (42.2%) drug-drug interactions were reported. A total of 75 (12%) cases of wrong dose of patient`s clinical condition, age at the prescription stage, of which 72.6% were overdose, 22.6% were dose too low and 6.6% inappropriate liver and kidney failure. In terms severity category of medication error, 89.3% (n=67) were “1” or incident, and 10.6% (n=8) were “0” or near miss. Of the 7 contraindicated drugs, 3 were “1a” and 4 were “1b” severity category. Conclusion: role of pharmacists is important in the planning of inpatient pharmacotherapy and is important in improving the quality of clinical care.